Arzneimittelforschung nach der Zulassung-Ziele, Methoden und Qualitätsanforderungen-

This publication has 9 references indexed in Scilit:

• Explanatory and pragmatic attitudes in therapeutical trials
  Published by Elsevier ,2004
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
  1992
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
  Published by Elsevier ,1992
• Good Clinical Practice for Trials on Medicinal Products in the European Community: CPMP Working Party on Efficacy of Medicinal Products
  Basic & Clinical Pharmacology & Toxicology, 1990
• CAST and beyond. Implications of the Cardiac Arrhythmia Suppression Trial. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
  Circulation, 1990
• [Glossary of the most important terms in the evaluation of treatments].
  1989
• Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
  New England Journal of Medicine, 1989
• Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPS
  The American Journal of Cardiology, 1988
• Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods.
  BMJ, 1981